New data on epidurals and labor progress

Article

Epidural anesthesia using low concentrations of bupivacaine doesn't seem to increase the risk of Cesarean delivery, but may increase the likelihood of an instrumental vaginal delivery in nulliparous women, according to a recent meta-analysis.

The authors of the review, which included data from seven randomized, controlled trials, reported the risk of an instrumental vaginal delivery in women receiving epidural anesthesia to be about twice that of women not receiving an epidural. Women receiving the regional anesthesia also had longer second-stage labor, although their newborns seemed unharmed by it.

On a more positive note, epidurals seem to successfully do what they are supposed to do: provide adequate pain relief. Fewer of the women receiving epidurals changed to parenteral opioids than vice versa. And the neonates of women receiving epidurals were less likely to need naloxone than the neonates of women who received opioid analgesia.

Liu EHC, Sia ATH. Rates of caesarean section and instrumental vaginal delivery in nulliparous women after low concentration epidural infusions or opioid analgesia: Systematic review. BMJ. 2004;328:1410-1412.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Eran Bornstein, MD, highlights early signs of preeclampsia clinicians need to know | Image Credit: northwell.edu.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening | Image Credit: northwell.edu.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.